Target intelligence / Profile preview

Gut hormone regulation

Molecular classification
Other
01

Overview

"Gut hormone regulation" refers broadly to the complex physiological processes governing the secretion and action of more than 20 different peptide hormones produced by enteroendocrine cells throughout the gastrointestinal tract. These hormones—including GLP‑1, GIP, CCK, PYY, ghrelin, secretin, gastrin—play pivotal roles in controlling appetite/satiety signals between the gut and brain; regulating glucose metabolism via effects on pancreatic insulin/glugacon secretion; modulating gastrointestinal motility; influencing energy expenditure; and maintaining overall metabolic homeostasis[2][3][7]. Dysregulation of these hormonal pathways is implicated in diseases such as obesity and type 2 diabetes mellitus. Therapeutic strategies increasingly focus on mimicking or enhancing beneficial actions of specific gut peptides through pharmacological agents that act on their respective receptors[4][9]. The term “Gut hormone regulation” does not refer to a single molecular entity but rather an integrated physiological system involving multiple distinct molecules with diverse functions across metabolic health. If you need structured information about any specific gut-derived molecule/receptor—such as “Glucagon-like peptide 1 receptor”—please specify that target for detailed data extraction according to your schema.

Other names
Glucagon-like peptide 1 (GLP-1)Gastric inhibitory polypeptide (GIP)Cholecystokinin (CCK)Peptide YY (PYY)GhrelinMotilinSecretinGastrin
02

Mechanism of action

Not applicable to "gut hormone regulation" as a whole. For individual targets such as the GLP‑1 receptor, mechanisms include agonism to enhance insulin secretion and satiety; for DPP‑4 inhibitors, inhibition of enzyme breakdown prolongs incretin action

03

Biological functions

Regulation of appetiteGlucose homeostasisEnergy balanceGastrointestinal motilitySatiety signaling
04

Disease associations

ObesityType 2 diabetes mellitusMetabolic syndrome
05

Safety considerations

Not applicable at the level of "gut hormone regulation." Safety concerns pertain to drugs targeting specific receptors/hormones.
06

Interacting drugs

GLP‑1 receptor agonists (e.g., semaglutide, liraglutide)

1 more in the full profile.

07

Biomarkers

GLP‑1GIP

Beyond the preview

Go deeper on Gut hormone regulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut hormone regulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call